Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
39 participants
INTERVENTIONAL
2011-01-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is a prospective randomized multicenter study. Comparing only fractures dislocated more than 30 degrees.
One group will be operated with intramedullary pins and one group will be treated conservatively with reduction and then Plaster of Paris for 3 weeks.
All patients will be followed up after 3, 6 and 12 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conservative or Operative Treatment of Fractures in the Neck of the 5th Metacarpal Bone
NCT01139528
Proximal Pole Fractures of the Scaphoid
NCT02398942
Treatement of Extension Fractures of the Distal Radius
NCT00492492
Comparison of Two Methods for Treatment of Colles´s Fracture
NCT00609479
Midterm (Min. 3yr) Follow-up of Patients With Single Spiral/Oblique Finger Metacarpal Fracture
NCT05869331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Operation
Closed reduction and operated for fixation with 2 antegrade intramedullary Kirschner wires.
Closed reduction and fixation with 2 pins
Closed reduction and fixation with 2 antegrade intramedullary Kirschner wires. Cast for 2 weeks. Control after 2 and 5 weeks. Thereafter a control after 3,6 and 12 months
Conservative treatment
Treated conservatively with reduction and then Plaster of Paris.
Reduction and Plaster of Paris
Closed reduction in local anesthesia and a Plaster of Paris for max. 3 weeks. Control after 1 and 3 weeks, thereafter control after 3,6 and 12 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Closed reduction and fixation with 2 pins
Closed reduction and fixation with 2 antegrade intramedullary Kirschner wires. Cast for 2 weeks. Control after 2 and 5 weeks. Thereafter a control after 3,6 and 12 months
Reduction and Plaster of Paris
Closed reduction in local anesthesia and a Plaster of Paris for max. 3 weeks. Control after 1 and 3 weeks, thereafter control after 3,6 and 12 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian University of Science and Technology
OTHER
St. Olavs Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivar Rossvoll, dr. med.
Role: STUDY_DIRECTOR
St. Olavs Hospital, orthopedic department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ålesund sjukehus, Helse Sunmøre
Ålesund, Møre og Romsdal, Norway
Kristiansund sykehus, Helse Nord Møre og Romsdal
Kristiansund-N, Møre og Romsdal, Norway
Molde sykehus, Helse Nordmøre og Romsdal
Molde, Møre og Romsdal, Norway
Sykehuset Namsos, Helse Nord-Trøndelag
Namsos, Nord -Trøndelag, Norway
Sykehuset i Vestfold-Tønsberg
Tønsberg, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOSL-2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.